Anastomosis Devices Industry Overview
The global anastomosis devices market size was valued at USD 3.58 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.6% from 2022 to 2030. Rising surgical procedures along with the growing prevalence of cardiovascular and gastrointestinal diseases are the key trends escalating market growth. The surgical practice has been considerably impacted by the outbreak of COVID-19. The pandemic has created challenges for general surgery practice. It has had ramifications for ways of working, open vs minimally invasive, surgical techniques, patient and staff safety, theatre workflow, training, and education. All specialisms have had to triage the importance of their regular surgical procedures and think about non-surgical management options where possible. Many elective or semi-elective procedures including gastrointestinal malignancies have been suspended. However, the market will witness the demand after the commencement of these surgeries at full force.
Moreover, the demand for improved patient outcomes will drive the uptake of novel innovations in anastomosis devices and contributes to market growth. For instance, in December 2020, India Medtronic Private Limited, a wholly-owned subsidiary of Medtronic introduced EEA Circular Stapler with Tri-Staple Technology. This is the first 3-row Circular Stapler with wide-ranging height staples is indicated for use in colorectal procedures.
Gather more insights about the market drivers, restraints, and growth of the Global Anastomosis Devices market
The introduction of technologically-advanced products and favorable reimbursement scenarios in cardiac procedures, which comprises Coronary Bypass Graft Surgery (CABG), open-heart valve replacement, and angioplasty in developed countries are boosting the growth of the market for anastomosis devices. For instance, Medicare Part B covers coronary artery bypass graft surgery, coronary angioplasty, valve repair & replacement, and other comprehensive Cardiac Rehabilitation (CR) programs.
The outbreak of COVID-19 impacted elective procedures. Restrictions of COVID-19 resulted in postponements to the number of procedures performed. Presently most countries have elevated restrictions on elective procedures. Consequently, there would be lucrative demand for anastomosis devices as these procedures start with full force. Besides, demand for healthier patient outcomes will drive the introduction of advanced technologies in anastomosis devices and promotes market growth. For instance, in October 2020, GI Windows Corp. raised $16.4 million in a Series A-1 funding that involved investment from Johnson & Johnson Innovation and others. The funds are allotted to improve the development and clinical trials of the firm’s anastomosis technology.
Browse through Grand View Research's Medical Devices Industry Research Reports.
Cardiovascular Anastomosis Devices Market - The global cardiovascular anastomosis devices market size was valued at USD 1.10 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.5% from 2022 to 2030.
General Surgery Devices Market - The global general surgery devices market size was valued at USD 14.75 billion in 2021 and is expected to grow at a CAGR of 8.29% from 2022 to 2030.
Anastomosis Devices Market Segmentation
Grand View Research has segmented the global anastomosis devices market based on product type, application, end-user, and region:
Anastomosis Devices Product Type Outlook (Revenue, USD Million, 2017 - 2030)
- Disposable
- Reusable
Anastomosis Devices Application Outlook (Revenue, USD Million, 2017 - 2030)
- Cardiovascular Surgery
- Gastrointestinal Surgery
- Others
Anastomosis Devices End-user Outlook (Revenue, USD Million, 2017 - 2030)
- Hospitals
- Ambulatory Care Center & Clinics
Anastomosis Devices Regional Outlook (Revenue, USD Million, 2017 - 2030)
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
Market Share Insights
March 2021: Vascular Graft Solutions Ltd. received a receipt of marketing authorization from the FDA for the VIOLA. This is a new device for clampless proximal anastomosis in CABG.
Key Companies profiled:
Some of the prominent players operating in the global anastomosis devices market are:
- Medtronic
- LivaNova PLC
- MAQUET Holding B.V. & Co. KG.
- Dextera Surgical Inc.
- Vitalitec Internaional Inc.
- Synovis Micro Companies Alliance, Inc.
- Ethicon US, LLC
- Peters Surgical
Order a free sample PDF of the Anastomosis Devices Market Intelligence Study, published by Grand View Research.
No comments:
Post a Comment